Ninety One (UK)
RPRX icon

Ninety One (UK)’s Royalty Pharma RPRX Stock Holding History

Ninety One (UK)’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$303K Sell
5,186
-4,351
-46% -$257K ﹤0.01% 274
2026
Q2 		$535K Buy
+9,537
New +$496K ﹤0.01% 206

Other funds holding RPRX

Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Triasima Portfolio Management
Triasima Portfolio Management Montreal, Quebec, Canada $758M AUM 48.16% 1-Year Est. Return
Sumitomo Mitsui DS Asset Management
Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.8B AUM 30.39% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
ASR Vermogensbeheer
ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Ninety One (UK)'s RPRX Position: Q3 2026 in Review

Ninety One (UK) reduced its Royalty Pharma (RPRX) stake by 46% in Q3 2026, selling an estimated $257K and leaving 5,186 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #274.

Ninety One (UK) first reported a position in RPRX in Q2 2026 and has held it in 2 quarters since. The position peaked at $535K in Q2 2026. 74 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Ninety One (UK) held 5,186 shares of Royalty Pharma worth $303K as of Q3 2026.
  • Ninety One (UK) sold 4,351 Royalty Pharma shares in Q3 2026, an estimated $257K.
  • Royalty Pharma made up ﹤0.01% of Ninety One (UK)'s portfolio in Q3 2026, its #274 holding.
  • Ninety One (UK) first reported a position in Royalty Pharma in Q2 2026 and has held it in 2 quarters since.
  • Ninety One (UK)'s Royalty Pharma position peaked at $535K in Q2 2026.
  • 74 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Ninety One (UK)'s 13F filing for Q3 2026, filed 15 Oct 2026.